Radiation-induced lung injury: assessment and management

AN Hanania, W Mainwaring, YT Ghebre, NA Hanania… - Chest, 2019 - Elsevier
Radiation-induced lung injury (RILI) encompasses any lung toxicity induced by radiation
therapy (RT) and manifests acutely as radiation pneumonitis and chronically as radiation …

[HTML][HTML] Current landscape of palliative radiotherapy for non-small-cell lung cancer

R Jumeau, F Vilotte, AD Durham… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
Radiotherapy (RT) is a cornerstone in the management of advanced stage III and stage IV
non-small-cell lung cancer (NSCLC) patients. Despite international guidelines, clinical …

[HTML][HTML] Modern radiation further improves survival in non-small cell lung cancer: an analysis of 288,670 patients

M Cheng, S Jolly, WO Quarshie, N Kapadia… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background: Radiation therapy plays an increasingly important role in the treatment of
patients with non-small-cell lung cancer (NSCLC). The purpose of the present study is to …

Bronchoscopic ablative therapies for malignant central airway obstruction and peripheral lung tumors

U Chaddha, DK Hogarth, S Murgu - Annals of the American …, 2019 - atsjournals.org
Bronchoscopic ablative therapies have been applied safely and successfully for the
palliation of malignant central airway obstruction and have the potential for treating …

Stereotactic ablative body radiotherapy versus radical radiotherapy: comparing real-world outcomes in stage I lung cancer

I Phillips, S Sandhu, M Lüchtenborg, S Harden - Clinical Oncology, 2019 - Elsevier
Aims Stereotactic ablative body radiotherapy (SABR) is now considered the standard of care
for medically inoperable stage I non-small cell lung cancer (NSCLC). The English National …

Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: A review

H Doi, K Nakamatsu, Y Nishimura - International Journal of Clinical …, 2019 - Springer
Stereotactic body radiation therapy (SBRT) can yield excellent local tumor control, as well as
survival benefit comparable to that of surgery for early-stage lung cancer. However, in terms …

Socioeconomic factors associated with lack of treatment in early stage non-small cell lung cancer

SM Dalwadi, J Zhang, EH Bernicker, EB Butler… - Cancer …, 2019 - Taylor & Francis
With modern radiotherapy, stage I non-small cell lung cancer (S1NSCLC) cure is extended
to nonsurgical candidates. Despite this, some S1NSCLC remains untreated. We aim to …

Radiotherapy patterns of care for stage I and II non‐small cell lung cancer in Sydney, Australia

AD Nguyen, W Wong, N Beydoun… - Journal of Medical …, 2019 - Wiley Online Library
Introduction Curative radiotherapy is guideline treatment for inoperable patients of good
performance status with Stage I & II Non‐Small Cell Lung Cancer (NSCLC). The aim of this …

Radiothérapie stéréotaxique du cancer bronchique non à petites cellules de stade I. État de l'art en 2019 et recommandations: la stéréotaxie comme alternative à la …

H Kaiss, F Mornex - Cancer/Radiothérapie, 2019 - Elsevier
Résumé La radiothérapie en conditions stéréotaxiques (ou Stereotactic body radiation
therapy [SBRT]) pulmonaire est une technique actuellement bien implantée dans l'arsenal …

Diagnostic Imaging Advances

JH Donahue, J Bueno, JN Itri - Stereotactic Radiosurgery and Stereotactic …, 2019 - Springer
Safe and efficient high-dose radiation delivery to target tissue, while minimizing the
exposure and toxicity of adjacent non-target organs, is considered the paramount goal of …